题名 | Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial | 链接 | https://pubmed.ncbi.nlm.nih.gov/34942136/ |
https://pubmed.ncbi.nlm.nih.gov/34942136/ |